Status: Recruiting
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
The purpose of this study is to compare the efficacy and safety of nab-paclitaxel with solvent-based taxanes as first-line treatment for patients with advanced primary epithelial ovarian cancer (EOC), primary peritoneal carcinoma or fallopian tube carcinoma.
Participants needed: 538
Trial details
Phase: Phase 3Age: 18-75Biological sex: FemaleType: InterventionalSponsor: Women's Hospital School Of Medicine Zhejiang UniversityUpdated: Feb 11, 2025Locations: 11
Eligibility criteria
Epithelial ovarian cancer/tubal cancer/peritoneal cancer was diagnosed by histop... [+6]
Patients with low malignant potential ovarian tumors; [+10]